Precision Medicine–our new study reveals trends, R&D progress, and predicted revenues
Where is the Precision Medicine market heading? If you are involved in this sector you must read this newly updated report. This report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 375 pages report provides 271 tables, 267 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Precision Medicine Market. See how to exploit the opportunities.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.

Precision Medicine Market by Therapeutics

  • Cancer
  • Cardiovascular
  • Central Nervous System
  • Infectious Diseases
  • Immunology
  • Others

Precision Medicine Market by Technology

  • Companion Diagnostics
  • Biomarkers
  • Biobanking in Targeted Therapeutics
  • Pharmacogenomics
  • Molecular Diagnostics

Precision Medicine Market by End Users

  • Pharma & Biotech
  • Diagnostic Tool Companies
  • Healthcare IT/Big Data Companies
  • Clinical Laboratories

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:

North America

  • U.S.
  • Canada


  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Belgium
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • Singapore
  • The Philippines
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Medicine market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Precision Medicine Market will surpass $67 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Precision Medicine Market report helps you
In summary, our 375 pages report provides you with the following knowledge:

  • Revenue forecasts to 2030 for 5 regional and 22 key national markets– See forecasts for the Precision Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, Australia, Singapore, The Philippines, South Korea. UAE, Saudi Arabia and South Africa.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 14 of the major companies involved in the Precision Medicine market i.e. Abbott, GE Healthcare, Johnson & Johnson Services, Inc., Pfizer Inc., Laboratory Corporation of America Holdings, Danaher, Qiagen N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Novartis AG, GSK, Merck KGaA, F. Hoffmann-La Roche Ltd, and Amgen Inc.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.